J. Brüggen

567 total citations
11 papers, 483 citations indexed

About

J. Brüggen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Brüggen has authored 11 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Brüggen's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Cell Adhesion Molecules Research (3 papers). J. Brüggen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Cell Adhesion Molecules Research (3 papers). J. Brüggen collaborates with scholars based in Switzerland, Germany and Belgium. J. Brüggen's co-authors include Clemens Sorg, G. Zwadlo, Graeme Bilbe, Jan Delabie, L. Suter, L. Tarcsay, Karel Odink, Nico Cerletti, C Sorg and E.-B. Bröcker and has published in prestigious journals such as The EMBO Journal, Blood and International Journal of Cancer.

In The Last Decade

J. Brüggen

11 papers receiving 465 citations

Peers

Countries citing papers authored by J. Brüggen

Since Specialization

Citations

This map shows the geographic impact of J. Brüggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Brüggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Brüggen more than expected).

Fields of papers citing papers by J. Brüggen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Brüggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Brüggen. The network helps show where J. Brüggen may publish in the future.

Co-authorship network of co-authors of J. Brüggen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Brüggen. A scholar is included among the top collaborators of J. Brüggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Brüggen. J. Brüggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Preclinical Evaluation of Nilotinib Efficacy in an Imatinib-Resistant KIT-Driven Tumor Model 2010 ·Molecular Cancer Therapeutics ·Carleen Cullinane, Anthony Natoli, (unknown), Nelly Conus, Susan Jackson, J. Brüggen, Paul W. Manley, Grant A. McArthur	27
2	Localization of the gene (RSN) coding for restin, a marker for Reed-Sternberg cells in Hodgkin’s disease, to human chromosome band 12q24.3 and YAC cloning of the locus 1994 ·Cytogenetic and Genome Research ·Carl Hilliker, Jan Delabie, Frank Speleman, Graeme Bilbe, J. Brüggen, F. Van Leuven, Herman Van den Berghe	14
3	Restin in Hodgkin's Disease and Anaplastic Large Cell Lymphoma 1993 ·Leukemia & lymphoma ·Jan Delabie, Graeme Bilbe, J. Brüggen, F. Van Leuven, Chris De Wolf‐Peeters	8
4	Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma 1992 ·Blood ·Jan Delabie, (unknown), J. Brüggen, Bart De Strooper, F. Van Leuven, L. Tarcsay, Nico Cerletti, Karel Odink, Volker Diehl, Graeme Bilbe	37
5	Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. 1992 ·The EMBO Journal ·Graeme Bilbe, Jan Delabie, J. Brüggen, (unknown), Fred A.M. Asselbergs, Nico Cerletti, Clemens Sorg, Karel Odink, L. Tarcsay, (unknown)	66
6	Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. 1988 ·PubMed ·G. Zwadlo, J. Brüggen, (unknown), (unknown), Clemens Sorg	247
7	A tumor‐associated antigen expressed in melanoma cells with lower malignant potential 1985 ·International Journal of Cancer ·L. Suter, J. Brüggen, E.-B. Bröcker, Clemens Sorg	37
8	The expression of tumor-associated antigens in primary and metastatic human malignant melanoma. 1984 ·PubMed ·J. Brüggen, (unknown), L. Suter, K. Redmαnn, C Sorg	9
9	Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma 1983 ·European Journal of Cancer and Clinical Oncology ·W. Stenzinger, J. Brüggen, E. Macher, C Sorg	29
10	Monoclonal antibodies against human malignant melanoma. 1983 ·PubMed ·C Sorg, J. Brüggen, L. Suter, (unknown)	1
11	Chronic oxidant exposure and epidemic influenza 1971 ·Environmental Research ·(unknown), John F. Finklea, Carl M. Shy, J. Brüggen, Vaun A. Newill	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact